All In Biotech

Drug Trial Radar · NCT03752723

Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899)

A Phase 1b/2, Open Label, Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacodynamics and Antitumor Activity of GX-I7 in Combination With Pembrolizumab in Subjects With Refractory or Relapsed (R/R) TNBC

Last checked: Nov 19, 2026Latest source record: Mar 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

84

Actual

Start

Mar 27, 2019

Primary completion

May 11, 2023

Study completion May 11, 2023

Sponsor

Lead sponsor
Genexine, Inc.Industry
Sponsor type
Industry
Collaborators
Merck Sharp & Dohme LLC
First posted
Nov 26, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and tolerability of escalating doses GX-I7 in combination with standard dose pembrolizumab, and to evaluate objective response rate (ORR) in subjects with refractory or relapsed TNBC

Conditions

  • Triple Negative Breast Cancer

Interventions

  • GX-I7Drug

    i.m.

  • Pembrolizumab(KEYTRUDA®)Drug

    i.v.

  • CyclophosphamideDrug

    i.v.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence and nature of DLTsTime frame: during the first 5 weeks
  2. Incidence, nature and severity of adverse eventsTime frame: up to 24month
  3. Objective response rate (ORR)Time frame: up to 24month

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • National Cancer Center

    Goyang-si, South Korea

  • Gachon University Gil Medical Center

    Incheon, South Korea

  • Asan Medical Center

    Seoul, South Korea

  • Ewha Womans University Mokdong Hospital

    Seoul, South Korea

  • Gangnam Severance Hospital

    Seoul, South Korea

  • Korea University Anam Hospital

    Seoul, South Korea

  • Korea University Guro Hospital

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Seoul ST.Mary's Hospital

    Seoul, South Korea

  • Severance Hospital

    Seoul, South Korea

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, South Korea

  • Ajou Medical Center

    Suwon, Gyeonggi-do, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.